McKesson Exec VP and Chief Financial Officer Alan Seelenfreund, 52, named chairman of the prescription claims processor spin-off and McKesson Exec VP Rex Malson, 57, named a PCS director. Seelenfreund fills the board seat left vacant by Thomas Field, who resigned as chairman of both McKesson and PCS Sept. 7. Field took over as PCS chairman following the resignation of President and CEO Don Dahlin in July. PCS still is actively searching for Dahlin's replacement. John Pfeiffer is filling that post in the interim.
You may also be interested in...
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.